News

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.

A man from Columbia, Missouri, got a new heart and a second chance at life, marking the 1,000th heart transplant at Saint Luke's Mid America Heart Institute.

This week during Breast Cancer Awareness Month, we’re talking about metastatic breast cancer and Saint Luke’s Koontz Center—the region’s only center dedicated and designed specifically for these patients.

Saint Luke’s program becomes the 23rd institution in the U.S. to perform 1,000 heart transplants.

More than 100,000 people are on the wait list for a life-saving transplant—and more than 85% of those can be helped by a living donor.

KCTV talked to one local colon cancer survivor and Dr. Robert Amajoyi about the importance of screenings and when to start.

After being diagnosed with Stage 3 breast cancer and undergoing chemotherapy and radiation treatments, Jesse found her heart was failing from side effects of chemotherapy.

When Maribeth Kammert first learned she had cancer in 2015, her world came to a stop. It was early stage breast cancer. “I was at Beauty Brands with my mom when I got the call. I went into the bathroom because I didn’t know how I would react. I didn’t cry,” said Maribeth. “I just had this instinct that I was going to take care of it, and God was going to take care of me. And if the outcome wasn’t what I wanted, I’d be okay with that.”

When Shannon Clarke, a 48-year-old, retired police officer, received a heart from Saint Luke’s Mid America Heart Institute, he had no idea just how transformational it would be.